Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
All content for UKMFA is the property of Ian and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
Do No Harm UK Column Intverview with Dr David Cartland
UKMFA
1 hour 6 minutes
3 weeks ago
Do No Harm UK Column Intverview with Dr David Cartland
Since 2020, Dr David Cartland https://www.drdavidcartland.com/ has been an inspiration to many. From his courageous whistleblowing about the serious side effects of the covid jabs, to calling out corruption and challenging official medical narratives, he is the epitome of what it means to be a compassionate and ethical doctor. A highly experienced GP with a First-Class Honours degree in Biomedical Science and an MSc in Medical Research, David risked — and ultimately lost — his career to uphol...
UKMFA
Dr Elizabeth Evans makes this important statement about Puberty Blockers. The NHS is funding a highly this unethical experimental trial of puberty blockers on more than 200 children aged between 10 and 15. The Pathways trial began at the end of November at King's College London to "explore how puberty suppressing hormones impact the physical, social, and emotional wellbeing of young people with gender incongruence". They admit that, quote, doctors and researchers don't yet know for sure what ...
